Cancer Screening Protocol Improves Morbidity and Mortality

June 05, 2017

Long-term (10-year) follow-up of a cancer screening tool indicated more early cancer diagnoses, according to a study presented at the ASCO Annual Meeting (http://abstracts.asco.org/199/AbstView_199_190132.html).

Between 2006 and 2016, the researchers enrolled healthy individuals 20–80 years old and collected extensive clinical and epidemiologic data. Patients were examined by specialists in internal medicine, surgery, plastic surgery, obstetrics and gynecology, urology, oncology, oral surgery, gastroenterology, and others, and screening included:

A total of 6,258 women (49%) and 6,461 men (51%) with a mean age of 47 (± 11.5) years were screened.

New malignant lesions were detected in 389 individuals (1.75%), the most common of which were skin (n = 74; 0.6%), prostate (n = 62; 0.5%), thyroid (n = 51; 0.4%), breast (n = 36; 0.3%), colorectal (n = 22; 0.2%), ovarian (n = 19; 0.1%), uterine (n = 14; 0.1%), testicular (n = 12; 0.09%), lung (n = 10; 0.08%), and urinary (n = 9; 0.07%) cancers.

In addition, 28 patients (0.22%) had more than one cancer detected. Patients at advanced age and with a first-degree family history were more likely to have more than one cancer detected.

Twenty-eight patients with cancer (7.2%) died after 32.4 (± 28.1) months at a mean age of 69.4 (± 14.2) years, which the researchers noted was “significantly better than the expected cancer mortality.”

The APC I1307K variant was detected in 572 patients (4.8%), whereas the E1317Q variant was detected in 182 patients (1.5%). “Impressively, the APC I1307K carries an overall increased cancer risk,” the authors commented.

The following characteristics were statistically significantly associated with an increased risk for cancer (p < 0.05 for all):

“One-stop-shop screening, in the setting of a multidisciplinary outpatient clinic, is feasible and can prevent and detect cancer at an early stage,” the authors concluded. “It significantly improved morbidity and mortality.”


Copyright © 2017 by the Oncology Nursing Society. User has permission to print one copy for personal or unit-based educational use. Contact pubpermissions@ons.org for quantity reprints or permission to adapt, excerpt, post online, or reuse ONS Voice content for any other purpose.